Safety and efficacy of granulocyte–colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia

References

• Wengerter KR, Yang PM, Veith FJ, Gupta SK, Panetta TF. A twelve-year experience with the popliteal-to-distal artery bypass: the significance and management of proximal disease. J Vasc Surg. 1992;15:143–9; discussion 50–1.
   PubMed Web of Science ®Google Scholar
• Veith FJ, Gupta SK, Samson RH, Flores SW, Janko G, Scher LA. Superficial femoral and popliteal arteries as inflow sites for distal bypasses. Surgery. 1981;90:980–90.
   PubMed Web of Science ®Google Scholar
• Gu YQ. Determination of amputation level in ischaemic lower limbs. ANZ J Surg. 2004;74:31–3.
   PubMed Web of Science ®Google Scholar
• Esato K, Hamano K, Li TS, Furutani A, Seyama A, Takenaka H, . Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant. 2002;11:747–52.
   PubMed Web of Science ®Google Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, . Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427–35.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K, . Autologous bone-marrow mononu-clear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation. 2004;109:1215–8.
   PubMed Web of Science ®Google Scholar
• Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, Minagawa S, . Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J. 2004;68:1189–93.
   PubMed Web of Science ®Google Scholar
• Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care. 2005;28:2155–60.
   PubMed Web of Science ®Google Scholar
• Huang PP, Li SZ, Han MZ, Xiao ZJ, Yang RC, Qiu LG, . Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost. 2004;91:606–9.
   PubMed Web of Science ®Google Scholar
• Ishida A, Ohya Y, Sakuda H, Ohshiro K, Higashiuesato Y, Nakaema M, . Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J. 2005;69:1260–5.
   PubMed Web of Science ®Google Scholar
• Kawamura A, Horie T, Tsuda I, Ikeda A, Egawa H, Imamura E, . Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial. 2005;9:59–63.
   PubMed Web of Science ®Google Scholar
• Minamino K, Adachi Y, Okigaki M, Ito H, Togawa Y, Fujita K . Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells. 2005;23:347–54.
   PubMed Web of Science ®Google Scholar
• Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res. 2003;40:368–77.
   PubMed Web of Science ®Google Scholar
• Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation. 2003;107:3093–100.
   PubMed Web of Science ®Google Scholar
• Wagner FW, Jr. The diabetic foot. Orthopedics. 1987;10:163–72.
   PubMed Web of Science ®Google Scholar
• Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1–S296.
   Google Scholar
• Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
   PubMed Web of Science ®Google Scholar
• Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. J Vasc Surg. 2008;48(Suppl):53s–60s.
   Google Scholar
• Van Huyen JP, Smadja DM, Bruneval P, Gaussem P, Dal-Cortivo L, Julia P, . Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol. 2008;21:837–46.
   PubMed Web of Science ®Google Scholar
• Lachmann N, Nikol S. Therapeutic angiogenesis for peripheral artery disease: stem cell therapy. Vasa. 2007;36:241–51.
   PubMedGoogle Scholar
• Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, . Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J. 2007;71:196–201.
   PubMed Web of Science ®Google Scholar
• Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, . Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 2008;156:1010–8.
   PubMed Web of Science ®Google Scholar
• Van Tongeren RB, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJ, Stiggelbout AM, . Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino). 2008;49:51–8.
   PubMed Web of Science ®Google Scholar
• Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105:71–7.
   PubMed Web of Science ®Google Scholar
• Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, . Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–8.
   PubMed Web of Science ®Google Scholar
• Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, . Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–8.
   PubMed Web of Science ®Google Scholar
• Takagi Y, Omura T, Yoshiyama M, Matsumoto R, Enomoto S, Kusuyama T, . Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia. J Pharmacol Sci. 2005;99:45–51.
   PubMed Web of Science ®Google Scholar
• Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation. 1990;(5-Suppl)82:IV3–8.
   PubMed Web of Science ®Google Scholar
• Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, . Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs. 2006;9:226–33.
   PubMedGoogle Scholar
• Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science. 1997;276:71–4.
   PubMed Web of Science ®Google Scholar
• Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702–12.
   PubMed Web of Science ®Google Scholar
• Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, . Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res. 2004;94:230–8.
   PubMed Web of Science ®Google Scholar
• Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, . Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104:1046–52.
   PubMed Web of Science ®Google Scholar